More Information about Cellular Health Research
Scientific publications by
Dr. Rath's Research Institute
During his career Dr. Rath
has made scientific
discoveries that rank among the most important discoveries
of all time in the field of medicine.
Most importantly, his groundbreaking
discoveries in the field of medicine will improve the health and life
of all people for generations to come.
Among the discoveries made by
Dr. Rath the following rank highest:
- The discovery that atherosclerosis, heart attacks and strokes are
an early form of scurvy caused by a chronic vitamin deficiency of the
vascular wall.
Read about it in Dr. Rath’s book ‘The
Heart’. (PDF, 1.43 MB)
- The discovery that long-term vitamin deficiency is also the primary
cause of high blood pressure, heart failure, circulatory problems in
diabetes and other related cardiovascular diseases.
Read about it in Dr. Rath’s book ‘The
Heart’. (PDF, 1.43 MB)
- The discovery that cancer growth and metastasis can be prevented by
the optimum supply of lysine and other natural substances blocking the
enzymatic digestion of the connective tissue by cancer cells.
Read about it in Dr. Rath’s book ‘Cancer’.
(PDF, 655 kB)
- The foundation of Cellular Medicine, defining the optimum supply of
vitamins and other bio-energy molecules as the medical breakthrough
that will allow the prevention, treatment and eventually the eradication
of today's most common diseases.
Scientists at the Dr. Rath Research Institute conduct cutting-edge research in natural health based on Dr. Rath’s scientific discoveries and the understanding of the critical role of essential nutrients in restoring and maintaining health at the deepest and most important level in the human body – the cellular level. This level has been totally neglected by the pharmaceutical industry. Our research findings have been presented at dozens of scientific conferences around the world and published in numerous respected, peer-reviewed biomedical journals and Web sites.
Scientific Publications:
A Specific Combination Of Ascorbic Acid, Lysine, Proline And Epigallocatechin Gallate Inhibits Proliferation And Extracellular Matrix Invasion Of Various Human Cancer Cell Lines
Shrirang P Netke, M Waheed Roomi, Vadim Ivanov, Aleksandra Niedzwiecki* and Matthias Rath
Matthias Rath, Inc., Research and Development, Santa Clara, CA 95054
Cytotxic Effect of Lipophlic Substitution at 2-, 6-, and 2,6-Positions
in Ascorbic Acid and Expression of Matrix Metalloproteinases in Hep G2
Cells, Melanoma Cells and Norman Human Dermal Fibroblast.
M.W. Roomi, S. Netke, V. Ivanov, A. Niedzwiecki and M. Rath
J. Am. Coll. Nutr. 20: 43, 2001
Inhibitory effects of ascorbic acid, proline
and lysine supplementation on Matrigel invasion by human breast cancer
cells, MDA-MB231.
S Netke, Ph.D., V Ivanov , MD. Ph.D., W. Roomi, Ph. D., A Niedzwiecki,
Ph. D., Matthias Rath, M.D.
Presented at: 19th Annual Miami Breast Cancer Conference, Miami Beach,
Florida, February 27 – March 3, 2002. Published in: Conference Proceedings
Cellular Medicine Research Breakthroughs
in the Control of Diseases: Report on Scientific Research
S Netke, Ph.D., V Ivanov , MD. Ph.D., W. Roomi, Ph. D., A Niedzwiecki,
Ph. D., Matthias Rath, M.D.
Presented at: 21st Century Medical Advances in the Treatment of Cancer
and Aging, Miami , Fl, March 22-24, 2003; Published in: Conference Proceedings
Nutritional supplement program halts progression of early coronary atherosclerosis.
M. Rath, M.D.
Controversies in Cardiovascular Nutrition, Stanford University Medical
Center, Stanford, CA, May 4, 2002
Metastatic and Cytotoxic Effects of Ascorbigen and iso-Ascorbigen in
Human Cancer Cell Lines.
M.W. Roomi, A. Bogale, V. Ivanov, S. Netke, A. Niedzwiecki and M. Rath,
J. Am. Coll. Nut. 21: 54, 2002
Matrix Metalloproteinase-2 Inhibition
and Invasion Potential in Human Chondrocytes by a natural anti-cancer
formula - a Specific Mixture of Nutrients Containing Lysine, Proline,
Ascorbic Acid and Epigallocatechin Gallate.
M.W. Roomi, S.P. Netke, V. Ivanov, M. Rath and A. Niedzwiecki
Presented at: American Association of Cancer Research Special Conference
in Cancer Research: Proteases, Extracellular Matrix and Cancer, Hilton
Head Island, South Carolina, Oct 9-13, 2002.
A Natural Anti-Cancer Formula - A Specific Formulation of Nutrients Containing
Lysine,Proline, Ascorbic Acid, and Epigallocatechin Gallate Inhibits Matrix
Metalloproteinases
Activity and Invasion Potential of Human Cancer Cell Lines.
M.W. Roomi, S.P. Netke, V. Ivanov, M. Rath and A. Niedzwiecki
Presented
at: European Organization for Research and Treatment of Cancer (EORTC),
AACR and NCI Symposium on Molecular Targets and Cancer Therapeutics,
Frankfurt, Germany, Nov 19-22, 2002; Published in: European Cancer Journal,
38, Suppl.7/Abs.280, 2002
Antitumorigenic Activity of a Natural Anti-Cancer Formula in Human Breast
Cancer Lines MDA-MB-231 and MCF-7.
Roomi, M.W., Ivanov, V., Rath, M. and Niedzwiecki,
A.
Presented at: The 8th Annual Multidisciplinary Symposium on Breast Disease,
Amelia Island, FL, February 13-16, 2003; Published in: Conference Proceedings
A randomized, double-blind placebo-controlled clinical study documents
the benefits of a vitamin program as an adjunct therapy in patients with
paraxysmal atrial arrhytmia.
Matthias Rath M.D. and Aleksandra Niedzwiecki Ph.D.
14th Madrid Arrhytmia Meeting, Madrid, Spain, February 27-28, 2003
A novel in vitro bioassay for screening matrix metalloproteinases activity
in human cancer cell lines
M Waheed Roomi, Shirang P Netke, Vadim Ivanov, Matthias Rath and Aleksandra
Niedzwiecki
Proceedings of the American Association for Cancer Research 44:4559(2003)
Inhibitory Effect of a Natural Anti-Cancer Formula - A Specific Formulation
of Nutrients Containing Lysine, Proline, Ascorbic Acid and Epigallocatechin
Gallate
on the Matrix Metalloproteinases Activities and Invasion of Human Fibrosarcoma
HT-1080 Cells
MW Roomi, V Ivanov, SP Netke, M Rath and A Niedzwiecki
FASEB Journal (2003) 8452
Letter to Editor: Antioxidant supplements and simvastatin-niacin therapy.
Netke S, Ivanov V, Roomi W, Niedzwiecki A, Rath M.
Arterioscler Thromb Vasc Biol. (2001) 21, 2099-2100.
|
